Variant report
Variant | rs17051000 |
---|---|
Chromosome Location | chr3:50578281-50578282 |
allele | A/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:50392345..50395062-chr3:50577174..50579262,2 | K562 | blood: | |
2 | chr3:50477103..50478834-chr3:50577541..50580324,2 | MCF-7 | breast: | |
3 | chr3:50574744..50576810-chr3:50578227..50580439,2 | K562 | blood: | |
4 | chr3:50407190..50409972-chr3:50577719..50580221,2 | K562 | blood: | |
5 | chr3:50383950..50386252-chr3:50576289..50578931,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000004838 | Chromatin interaction |
ENSG00000114388 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1077215 | 0.88[CHB][hapmap];1.00[JPT][hapmap] |
rs1107312 | 0.84[CHB][hapmap];0.88[JPT][hapmap];0.83[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs12486143 | 0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs12486717 | 0.88[AMR][1000 genomes] |
rs12487817 | 0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12489607 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes] |
rs12491440 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes] |
rs12491812 | 0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs12492093 | 0.90[AMR][1000 genomes] |
rs12492540 | 0.90[AMR][1000 genomes] |
rs12492982 | 0.90[AMR][1000 genomes] |
rs12494094 | 0.81[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12494326 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs12494707 | 0.81[AMR][1000 genomes] |
rs12495399 | 0.88[CHB][hapmap];1.00[JPT][hapmap] |
rs17050991 | 0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs17050995 | 0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs17051043 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes] |
rs17051045 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes] |
rs17051403 | 0.87[CHB][hapmap];1.00[JPT][hapmap] |
rs1872184 | 0.93[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs1894459 | 0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2035484 | 0.88[CHB][hapmap];1.00[JPT][hapmap] |
rs2076927 | 0.88[AMR][1000 genomes] |
rs2170840 | 0.88[CHB][hapmap];1.00[JPT][hapmap] |
rs2227292 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs2227293 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2239750 | 0.84[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs2239751 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs2239752 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2239753 | 0.82[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2285090 | 0.88[CHB][hapmap];1.00[JPT][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs3749265 | 0.89[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs3752449 | 0.86[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs3792323 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.86[ASN][1000 genomes] |
rs3806706 | 0.85[CHB][hapmap];0.89[JPT][hapmap];0.88[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs4476497 | 0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs4640555 | 0.88[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs4688705 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes] |
rs4688707 | 0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4688709 | 0.88[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs4688710 | 0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs4688713 | 0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs4688715 | 0.88[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs4688716 | 0.91[AMR][1000 genomes];0.97[ASN][1000 genomes] |
rs56170012 | 0.93[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs56856095 | 0.88[AMR][1000 genomes] |
rs57910827 | 0.90[AMR][1000 genomes] |
rs58427389 | 0.81[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs59036236 | 0.88[AMR][1000 genomes] |
rs60552073 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs60877431 | 0.90[AMR][1000 genomes] |
rs61193866 | 0.92[AMR][1000 genomes];0.89[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs61316441 | 0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs61574029 | 0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs61613532 | 0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs616689 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.85[ASN][1000 genomes] |
rs6446208 | 0.81[AMR][1000 genomes] |
rs650655 | 0.81[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs6766638 | 0.93[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs6771348 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs6783922 | 0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs728902 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes] |
rs72938758 | 0.90[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs72942785 | 0.90[AMR][1000 genomes] |
rs72942794 | 0.90[AMR][1000 genomes] |
rs73835531 | 0.95[AMR][1000 genomes];0.89[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs743753 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.89[ASN][1000 genomes] |
rs745356 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs762889 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.91[ASN][1000 genomes] |
rs808148 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs876103 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs876104 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes] |
rs876105 | 0.89[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes] |
rs9814874 | 0.85[CHB][hapmap] |
rs9868889 | 0.81[AMR][1000 genomes];0.82[ASN][1000 genomes] |
rs9879397 | 0.88[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv523662 | chr3:50144951-50584999 | Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 101 gene(s) | inside rSNPs | diseases |
2 | esv1821728 | chr3:50156142-50657253 | Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 109 gene(s) | inside rSNPs | diseases |
3 | nsv470561 | chr3:50158774-50584999 | Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 99 gene(s) | inside rSNPs | diseases |
4 | nsv876770 | chr3:50158774-50609624 | Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 103 gene(s) | inside rSNPs | diseases |
5 | nsv1001993 | chr3:50187646-50640808 | Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 104 gene(s) | inside rSNPs | diseases |
6 | esv3584502 | chr3:50368278-50659741 | Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
7 | nsv432419 | chr3:50388396-50637496 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
8 | nsv1013225 | chr3:50440826-50700448 | Flanking Active TSS Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
9 | nsv536566 | chr3:50440826-50700448 | Genic enhancers Weak transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
10 | nsv984540 | chr3:50473691-50669310 | Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 28 gene(s) | inside rSNPs | diseases |
11 | nsv1012501 | chr3:50483037-50679591 | Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
12 | nsv536567 | chr3:50483037-50679591 | Bivalent Enhancer Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
13 | nsv460532 | chr3:50536273-50616049 | Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
14 | nsv590272 | chr3:50536273-50616049 | Weak transcription Enhancers Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 17 gene(s) | inside rSNPs | diseases |
15 | nsv460533 | chr3:50574213-50678151 | Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
16 | nsv590273 | chr3:50574213-50678151 | Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:50576400-50578600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr3:50577400-50579800 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr3:50577400-50586400 | Weak transcription | Brain Anterior Caudate | brain |
4 | chr3:50577600-50579800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr3:50577600-50583200 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr3:50577600-50583200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr3:50577600-50583200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr3:50577600-50583200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr3:50577800-50580000 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
10 | chr3:50578000-50578600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr3:50578000-50579200 | Enhancers | K562 | blood |
12 | chr3:50578200-50579200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |